Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Coinfection with Streptococcus pneumoniae modulates the B cell response to influenza virus.

Wolf AI, Strauman MC, Mozdzanowska K, Whittle JR, Williams KL, Sharpe AH, Weiser JN, Caton AJ, Hensley SE, Erikson J.

J Virol. 2014 Oct;88(20):11995-2005. doi: 10.1128/JVI.01833-14. Epub 2014 Aug 6.

2.

Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease.

Wolf AI, Strauman MC, Mozdzanowska K, Williams KL, Osborne LC, Shen H, Liu Q, Garlick D, Artis D, Hensley SE, Caton AJ, Weiser JN, Erikson J.

Virology. 2014 Aug;462-463:254-65. doi: 10.1016/j.virol.2014.06.019. Epub 2014 Jul 5.

3.

Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.

Laidlaw BJ, Decman V, Ali MA, Abt MC, Wolf AI, Monticelli LA, Mozdzanowska K, Angelosanto JM, Artis D, Erikson J, Wherry EJ.

PLoS Pathog. 2013 Mar;9(3):e1003207. doi: 10.1371/journal.ppat.1003207. Epub 2013 Mar 14.

4.

Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.

Wolf AI, Mozdzanowska K, Williams KL, Singer D, Richter M, Hoffmann R, Caton AJ, Otvos L, Erikson J.

PLoS One. 2011;6(12):e28445. doi: 10.1371/journal.pone.0028445. Epub 2011 Dec 13.

5.

Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI.

Wolf AI, Mozdzanowska K, Quinn WJ 3rd, Metzgar M, Williams KL, Caton AJ, Meffre E, Bram RJ, Erickson LD, Allman D, Cancro MP, Erikson J.

J Clin Invest. 2011 Oct;121(10):3954-64. doi: 10.1172/JCI57362. Epub 2011 Sep 1.

6.

Pharmacologic activation of the innate immune system to prevent respiratory viral infections.

Cheng G, Wang LC, Fridlender ZG, Cheng GS, Chen B, Mangalmurti NS, Saloura V, Yu Z, Kapoor V, Mozdzanowska K, Moon E, Sun J, Kreindler JL, Cohen NA, Caton AJ, Erikson J, Albelda SM.

Am J Respir Cell Mol Biol. 2011 Sep;45(3):480-8. doi: 10.1165/rcmb.2010-0288OC. Epub 2010 Dec 10.

7.

Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection.

Decman V, Laidlaw BJ, Dimenna LJ, Abdulla S, Mozdzanowska K, Erikson J, Ertl HC, Wherry EJ.

J Immunol. 2010 May 1;184(9):5151-9. doi: 10.4049/jimmunol.0902063. Epub 2010 Apr 5.

9.

Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2.

Feng J, Zhang M, Mozdzanowska K, Zharikova D, Hoff H, Wunner W, Couch RB, Gerhard W.

Virol J. 2006 Dec 6;3:102.

10.

Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components.

Mozdzanowska K, Feng J, Eid M, Zharikova D, Gerhard W.

Virology. 2006 Sep 1;352(2):418-26. Epub 2006 Jun 14.

11.

Prospects for universal influenza virus vaccine.

Gerhard W, Mozdzanowska K, Zharikova D.

Emerg Infect Dis. 2006 Apr;12(4):569-74.

12.

Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.

Zhang M, Zharikova D, Mozdzanowska K, Otvos L, Gerhard W.

Mol Immunol. 2006 Jul;43(14):2195-206. Epub 2006 Feb 10.

PMID:
16472860
13.

Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.

Zharikova D, Mozdzanowska K, Feng J, Zhang M, Gerhard W.

J Virol. 2005 Jun;79(11):6644-54.

16.
20.

CD4+ T cells are ineffective in clearing a pulmonary infection with influenza type A virus in the absence of B cells.

Mozdzanowska K, Furchner M, Maiese K, Gerhard W.

Virology. 1997 Dec 8;239(1):217-25.

21.

Role of the B-cell response in recovery of mice from primary influenza virus infection.

Gerhard W, Mozdzanowska K, Furchner M, Washko G, Maiese K.

Immunol Rev. 1997 Oct;159:95-103. Review.

PMID:
9416505
23.

Enhancement of antigen presentation of influenza virus hemagglutinin by the natural human anti-Gal antibody.

Galili U, Repik PM, Anaraki F, Mozdzanowska K, Washko G, Gerhard W.

Vaccine. 1996 Mar;14(4):321-8.

PMID:
8744560
24.
25.

Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity.

Liang S, Mozdzanowska K, Palladino G, Gerhard W.

J Immunol. 1994 Feb 15;152(4):1653-61.

PMID:
8120375
26.

[Epidemiology of contact hypersensitivity to rubber components in manufacturers of automobile tires at the Stomil plant].

Rubisz-Brzezińska J, Bogdanowski T, Brzezińska-Wcisło L, Mozdzanowska K, Bajcar S.

Przegl Dermatol. 1990 May-Jun;77(3):171-6. Polish.

PMID:
2147069
27.

[Treatment of systemic scleroderma with fucidin in relation to clinical evaluation and analysis of free amino acids in the serum].

Rubisz-Brzezińska J, Zebracka T, Mozdzanowska K, Mozdzanowski J.

Przegl Dermatol. 1986 Jul-Aug;73(4):305-11. Polish. No abstract available.

PMID:
3333865
28.

[Therapeutic trial with fucidin in systemic scleroderma].

Rubisz-Brzezińska J, Zebracka T, Mozdzanowski J, Mozdzanowska K.

Z Hautkr. 1984 Dec 1;59(23):1611-9. German.

PMID:
6395525
29.

Treatment of systemic scleroderma with fucidine with regard to some free amino acids contents before and after therapy.

Rubisz-Brzezińska J, Zebracka T, Mozdzanowska K, Mozdzanowski J.

Acta Derm Venereol. 1984;64(3):267-70.

PMID:
6204494
30.

[Studies on the effect of electromagnetic radiation on the hair cycle in guinea pigs].

Rubisz-Brzezińska J, Bendkowski W, Mozdzanowska K.

Przegl Dermatol. 1983 Mar-Apr;70(2):121-6. Polish. No abstract available.

PMID:
6647872
31.

[Treatment of systemic scleroderma with fucidin].

Rubisz-Brzezińska J, Zebracka T, Mozdzanowska K, Bendkowski W, Mozdzanowski J.

Przegl Dermatol. 1983 Mar-Apr;70(2):209-15. Polish. No abstract available.

PMID:
6359277

Supplemental Content

Loading ...
Support Center